NCT04544995 2026-01-21Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)GlaxoSmithKlinePhase 1 Terminated47 enrolled 43 charts
NCT06438783 2025-12-12TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Terminated20 enrolled
NCT03422679 2024-01-16Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesCellestia Biotech AGPhase 1/2 Terminated79 enrolled 22 charts
NCT00089245 2023-12-26Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal CancerY-mAbs TherapeuticsPhase 1 Terminated177 enrolled
NCT03458728 2023-12-04Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric PatientsBayerPhase 1/2 Terminated31 enrolled 17 charts
NCT03860207 2023-09-13Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor CancersY-mAbs TherapeuticsPhase 1/2 Terminated12 enrolled 15 charts
NCT04861948 2022-10-04IBI188 Combination Therapy in Solid TumorsInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Terminated9 enrolled
NCT01759303 2021-04-13Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the LungEmerald Clinical Inc.Phase 2 Terminated12 enrolled
NCT00617890 2018-08-23A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)Merck Sharp & Dohme LLCPhase 2 Terminated219 enrolled 13 charts
NCT01194284 2017-01-19Surveillance Study of Patients With Newly Diagnosed OsteosarcomaTakedaTerminated25 enrolled